Skip to content

Clinical trials

Completed Phase 3 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Status: Completed Clear all

289 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20016
200215
20038
200414
200520
200627
200710
200814
200917
201018
201129
201216
201311
201412
201512
20168
20176
20187
20196
202010
20216
20224
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company19
Forest Laboratories18
H. Lundbeck A/S18
Wyeth is now a wholly owned subsidiary of Pfizer18
AstraZeneca14
Otsuka Pharmaceutical Development & Commercialization, Inc.13
Takeda12
Sanofi11
Merck Sharp & Dohme LLC9
Pfizer9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder289
Depressive Disorder30
Mental Disorders11
Mood Disorders11
Psychotic Disorders11
Bipolar Disorder7
Anxiety Disorders5
Depressive Disorder, Treatment-Resistant5
Sleep Initiation and Maintenance Disorders5
Recurrence4

Trials

Showing 1 to 25 of 289. Each trial links to its page on Pharma Observatory.

189 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.